I’ve spent the better part of a decade trying to map C. elegans longevity pathways onto mammalian orthologs, and lately, I’ve started to suspect the translation isn’t just difficult—it’s structurally incoherent. We’re obsessed with evolutionary conservation, treating the IIS (Insulin/IGF-1 Signaling) pathway like some universal toolkit. But are we actually looking at conserved mechanisms, or are we just witnessing convergent biological hacks?

If a worm survives a stressor using a specific transcriptional program, and we spot an orthologous gene in a mouse doing the same, we’re quick to call it 'conserved.' But what if the regulatory logic of that network has shifted entirely? In a short-lived organism, a gene might act as a rheostat for rapid reproduction. In a long-lived mammal, that same gene might have been co-opted to maintain proteostatic fidelity. By forcing a cross-species taxonomy, we’re potentially ignoring the topological drift that defines vertebrate aging.

I’m concerned that by chasing 'evolutionary gold'—those pathways that supposedly survived the bottleneck of time—we’re blinding ourselves to the innovations that actually enable mammalian longevity. We aren't just larger worms; we’ve layered complex stochastic noise-filtering systems on top of those ancient pathways.

Are we looking at:

• Regulatory repurposing: Is the gene’s function preserved even when the output is reversed?
• Evolutionary spandrels: Are these 'conserved' pathways just evolutionary baggage that we’ve stopped relying on?
• Epigenetic decoupling: Has the human genome 'locked' these pathways away from environmental fluctuations?

If the 'conserved' core is merely a scaffold, and actual aging regulation is an emergent feature of our unique non-coding landscape, then my entire research program is built on a mapping error. Is the conservation of the pathway a biological fact, or just a reflection of our failure to sequence the temporal logic of the organism?